As was previously announced, MSD will serve as exclusive worldwide distributor for tissue allografts and bone paste processed by RTI for use in spinal surgery. Under the agreement, RTI remains responsible for processing human allograft tissue for the spine and regulatory compliance related to screening, testing and processing of this tissue. MSD is responsible for developing techniques and instrumentation for implantation of human allograft tissue, training and consultation with surgeons on custom implants, distribution and immediate delivery of available tissue and regulatory compliance related to distribution.

The agreement with Exactech is an exclusive worldwide distribution agreement for bone paste products processed by RTI for non-spinal musculoskeletal orthopedic procedures. The companies also have agreed to work together to develop new bone paste products for use in non-spinal musculoskeletal procedures.

Exactech and RTI are currently working to integrate their distribution networks into a single Exactech distribution team to best serve customer needs.

"We look forward to a long relationship with our exclusive distributors, Medtronic Sofamor Danek and Exactech, under these new agreements," said RTI President and CEO Brian K. Hutchison. "As a team, we can provide natural, biological solutions for hundreds of thousands of orthopedic patients."